× Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our privacy policy



meta|IO

Living evidence synthesis
about Immuno-Oncology drugs

Member of the meta|Evidence galaxy

Pathology  

Latest studies

TORCHLIGHT, 2024

breast cancer - triple negative

nab-paclitaxel

ICON, 2024

breast cancer - HR positive

nivolumab plus ipilimumab

Saphir02 Breast-Immuno, 2021

breast cancer HER 2 negative

durvalumab alone

Modul Cohort 4, 2023

metastatic/advanced - colorectal cancer (mCRC)

atezolizumab plus cometinib

Treatments

450
treatments 		  383
studies 		  1302
references
This project is supported by H2020 Qualitop, an EU-funded project, Hospices Civils de Lyon and CNRS UMR5558 LBBE.
     

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons